KPMG

Survey: Pharma execs focus on regulation and organic growth

Friday, June 22, 2012 12:09 PM

Pharmaceutical executives say they will focus as much time and energy ahead in navigating the regulatory environment as they will on organic growth, according to a recent survey by KPMG, the U.S. audit, tax and advisory firm.

More... »


KPMG: Outline contract obligations in sponsor-CRO relationships

Tuesday, July 26, 2011 12:28 PM

Pharma companies are increasingly looking to CROs, but a number of risks may be overlooked, according to KPMG.

More... »


Survey: U.S. M&A activity likely to increase

Thursday, July 14, 2011 12:45 PM

U.S. drug makers are likely to step up their acquisition activities in a bid to find new therapies, and they have the cash to do so, according to a survey by KPMG reported by Pharma-Times.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs